Assignee
CANCER RES INST OF CONTRA COST
US·2 granted patents·1 pending application·168 citations·filing 1995–2008
Top patents by PatentIndex Score
3 records- 0193US6309636B1Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptidesCANCER RES INST OF CONTRA COST·Filed 1995·Granted Oct 30, 2001·168 cites·13 claims
- 0258US7390635B2Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptidesCANCER RES INST OF CONTRA COST·Filed 2004·Granted Jun 24, 2008·0 cites·5 claims
- 0358US2009010848A1Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody PeptidesCANCER RES INST OF CONTRA COST·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CANCER RES INST OF CONTRA COST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →